Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
Clinical trial NCT04941274 · RECRUITING
Trial details
- NCT number
- NCT04941274
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-29
- Primary completion
- 2028-03-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.